Revolution Medicines, Inc.
RVMD Healthcare Biotechnology
Revolution Medicines, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $11.6 million, down 67.3% from fiscal 2022. In the quarter to June 2026, EPS fell 133.6%, free cash flow fell 70.0% and total debt rose 322.7%, each against the same quarter a year earlier.
Follow RVMD
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
2,025.68 | 2,289.30 | 1,852.96 | 644.94 | 577.05 | 440.74 | 122.76 | 69.59 | 9.08 |
Receivables |
— | — | 1.25 | 4.67 | 5.93 | 6.39 | 8.74 | 7.30 | — |
Other current assets |
— | — | — | — | — | — | — | 6.60 | 0.36 |
Total current assets |
2,075.04 | 2,327.63 | 1,879.28 | 660.19 | 589.77 | 454.12 | 133.98 | 85.43 | 9.44 |
Property, Plant, Equpment (Net) |
33.19 | 24.29 | 22.87 | 18.66 | 11.54 | 8.90 | 7.15 | 6.87 | 5.25 |
Long-Term Investments |
24.15 | 12.13 | — | 1.74 | 1.74 | 1.08 | 0.21 | 0.21 | — |
Goodwill and Intangible Assets (Total) |
70.41 | 71.28 | 72.35 | 73.42 | 74.48 | 75.55 | 76.62 | 77.69 | 0.00 |
Long-term assets (Other) |
19.64 | 5.44 | 10.06 | 4.59 | 2.50 | 1.39 | 2.78 | 0.59 | 0.38 |
Total non-current assets |
279.47 | 230.67 | 182.42 | 151.75 | 148.22 | 113.28 | 86.55 | 85.16 | — |
Total Assets |
2,354.51 | 2,558.30 | 2,061.71 | 811.93 | 737.99 | 567.40 | 220.53 | 170.59 | — |
Accounts Payable |
64.62 | 54.43 | 61.79 | 21.31 | 14.06 | 12.61 | 11.40 | 5.24 | 3.35 |
Accrued Expenses |
209.34 | 96.62 | 74.69 | 29.45 | 27.72 | 18.78 | 14.53 | 8.49 | — |
Current Part of Capital Lease |
— | — | — | — | — | — | — | — | 0.00 |
Current Part of Taxes to Pay |
— | — | — | — | — | — | — | — | 0.00 |
Current Revenue (Deferred) |
— | — | — | 4.46 | 12.36 | 12.11 | 17.12 | 16.83 | — |
Total current liabilities |
290.42 | 163.91 | 143.85 | 61.98 | 60.35 | 47.18 | 43.05 | 30.55 | 7.60 |
Long Term Debt (Total) |
268.45 | — | — | 57.43 | 60.42 | 28.99 | — | — | — |
Non-current Revenue (Deferred) |
— | — | — | — | 6.57 | 8.48 | 16.47 | 30.67 | 0.00 |
Long Term Tax Liability (Deferred) |
2.35 | 2.35 | 3.12 | 7.03 | 7.44 | 7.44 | 7.82 | 12.19 | — |
Minority Interests |
— | — | — | — | — | — | — | — | 0.00 |
Non-current Liabilities (Other) |
19.75 | 3.86 | 7.97 | 0.30 | 0.63 | 0.63 | 0.66 | 0.52 | 2.95 |
Total non-current liabilities |
432.79 | 129.18 | 91.66 | 64.76 | 75.07 | 45.55 | 24.94 | 43.38 | — |
Total liabilities |
723.21 | 293.10 | 235.51 | 126.74 | 135.42 | 92.73 | 67.99 | 73.93 | — |
Additional Paid In Capital |
4,497.14 | 4,001.67 | 2,963.34 | 1,388.30 | 1,055.57 | 740.10 | 4.74 | 1.30 | 0.00 |
Preferred Stock (Total) |
— | — | — | — | — | — | 305.11 | 205.08 | 0.00 |
Common Stock (Net) |
0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Retained Earnings |
(2,869.10) | (1,737.80) | (1,137.71) | (701.34) | (452.64) | (265.54) | (157.39) | (109.72) | (67.93) |
Treasury Stock |
— | — | — | — | — | — | — | — | 0.00 |
Shareholders Equity (Other) |
— | — | — | — | — | — | — | — | 0.00 |
Common Equity (Total) |
1,631.30 | 2,265.20 | 1,826.19 | 685.19 | 602.57 | 474.68 | (152.57) | (108.42) | (67.72) |
Shareholders Equity (Total) |
1,631.30 | 2,265.20 | 1,826.19 | 685.19 | 602.57 | 474.68 | 152.54 | 96.66 | — |
Shareholders Equity and Liabilities (Total) |
2,354.51 | 2,558.30 | 2,061.71 | 811.93 | 737.99 | 567.40 | 220.53 | 170.59 | — |
Shares (Common) |
197.00 | 185.90 | 164.68 | 90.41 | 74.14 | 66.60 | 3.29 | 3.21 | — |
Shares (Preferred) |
— | — | — | — | — | — | 39.60 | 29.60 | — |
Shareholders Equity (Tangible) |
1,560.89 | 2,193.93 | 1,753.85 | 611.77 | 528.08 | 399.12 | 75.91 | 18.97 | — |
Net Debt |
(1,757.23) | (2,289.30) | (1,852.95) | (587.51) | (516.63) | (411.75) | (122.76) | (69.59) | (9.08) |
Total Debt |
268.45 | — | — | 57.43 | 60.42 | 28.99 | 0.17 | 0.15 | — |